{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:46:24Z","timestamp":1793119584243,"version":"4.5.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:p>Atopic dermatitis (AD) is an inflammatory skin disease. Patients with AD are prone to develop anxiety and mood disorders. Aim of this study is to investigate if treatment with dupilumab may improve mental health status of patients affected by AD.<\/jats:p>\n          <jats:p>A total of 66 patients with severe AD were included: 24 subjects were candidate or have just started (one month) treatment with dupilumab, and 42 have been in treatment for one year.<\/jats:p>\n          <jats:p>25.8%, 30.3%, and 45.5% of the total sample showed, respectively, clinically significant anxiety, depression, and symptoms of Internet addiction. Patients with anxiety symptoms resulted to have more severe AD, more sleep problems (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.028), less quality of life (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.001), more severe depressive symptoms (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001), to be more frequently women (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.016), to be less frequently treated with dupilumab for one year (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.025). Similarly, patients with clinically significant depressive symptoms resulted to have more severe AD, more sleep problems (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.003), less quality of life (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001), more severe anxiety symptoms (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001), to be less frequently treated with dupilumab for one year (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.008).<\/jats:p>\n          <jats:p>Patients with AD treated for one year with dupilumab showed a better mental health profile in terms of less severe anxiety and depression with respect to their counterparts.<\/jats:p>","DOI":"10.1097\/yic.0000000000000511","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:00:10Z","timestamp":1696222810000},"page":"201-205","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?"],"prefix":"10.1097","volume":"39","author":[{"given":"Silvia Mariel","family":"Ferrucci","sequence":"first","affiliation":[{"name":"Dermatology Section, Fondazione IRCCS Ca\u2019 Granda, Ospedale Maggiore Policlinico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Tavecchio","sequence":"additional","affiliation":[{"name":"Dermatology Section, Fondazione IRCCS Ca\u2019 Granda, Ospedale Maggiore Policlinico"},{"name":"Department of Pathophysiology and Transplantation, University of Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Nicolini","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Department of Biomedical and Clinical Sciences Luigi Sacco, Luigi Sacco Hospital, University of Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Angileri","sequence":"additional","affiliation":[{"name":"Dermatology Section, Fondazione IRCCS Ca\u2019 Granda, Ospedale Maggiore Policlinico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Ceresa","sequence":"additional","affiliation":[{"name":"Department of Neurosciences and Mental Health, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Del Tordello","sequence":"additional","affiliation":[{"name":"Dermatology Section, Fondazione IRCCS Ca\u2019 Granda, Ospedale Maggiore Policlinico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Berti","sequence":"additional","affiliation":[{"name":"Dermatology Section, Fondazione IRCCS Ca\u2019 Granda, Ospedale Maggiore Policlinico"},{"name":"Department of Pathophysiology and Transplantation, University of Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Valerio","family":"Marzano","sequence":"additional","affiliation":[{"name":"Dermatology Section, Fondazione IRCCS Ca\u2019 Granda, Ospedale Maggiore Policlinico"},{"name":"Department of Pathophysiology and Transplantation, University of Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Buoli","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Transplantation, University of Milan"},{"name":"Department of Neurosciences and Mental Health, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,22]]},"reference":[{"key":"R1-20250802","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jaip.2020.12.007","article-title":"Sleep disturbances and atopic dermatitis: relationships, methods for assessment, and therapies.","volume":"9","author":"Bawany","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R2-20250802","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/YIC.0000000000000403","article-title":"Antidepressant psychopharmacology: is inflammation a future target?","volume":"37","author":"Benedetti","year":"2022","journal-title":"Int Clin Psychopharmacol"},{"key":"R3-20250802","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1111\/ijd.14763","article-title":"Impact of atopic dermatitis on quality of life in adults: a systematic review and meta-analysis.","volume":"59","author":"Birdi","year":"2020","journal-title":"Int J Dermatol"},{"key":"R4-20250802","doi-asserted-by":"crossref","first-page":"118245","DOI":"10.1016\/j.envpol.2021.118245","article-title":"Air pollution exposure and depression: a comprehensive updated systematic review and meta-analysis.","volume":"292","author":"Borroni","year":"2022","journal-title":"Environ Pollut"},{"key":"R5-20250802","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jad.2017.11.015","article-title":"The role of clock genes in the etiology of major depressive disorder.","volume":"234","author":"Buoli","year":"2018","journal-title":"J Affect Disord"},{"key":"R6-20250802","doi-asserted-by":"crossref","first-page":"100453","DOI":"10.1016\/j.bbih.2022.100453","article-title":"Is there an association between inflammatory\/anti-oxidant markers and the presence of psychotic symptoms or severity of illness in mood and psychotic disorders? A multi-centric study on a drug-free sample.","volume":"22","author":"Caldiroli","year":"2022","journal-title":"Brain Behav Immun Health"},{"key":"R7-20250802","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/bjd.12590","article-title":"Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods.","volume":"169","author":"Charman","year":"2013","journal-title":"Br J Dermatol"},{"key":"R8-20250802","first-page":"121","article-title":"Detecting psychological distress in cancer patients: validity of the italian version of the hospital anxiety and depression scale.","volume":"7","author":"Costantini","year":"1999","journal-title":"Support Care Cancer"},{"key":"R9-20250802","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaad.2019.03.037","article-title":"Burden of illness in adults with atopic dermatitis: analysis of national health and wellness survey data from France, Germany, Italy, Spain, and the United Kingdom.","volume":"81","author":"Eckert","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R10-20250802","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1192\/j.eurpsy.2021.2249","article-title":"A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa.","volume":"64","author":"Fabrazzo","year":"2021","journal-title":"Eur Psychiatry"},{"key":"R11-20250802","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jaad.2022.09.015","article-title":"Alcohol use disorder among adults with atopic dermatitis: a case-control study in the All of us research program.","volume":"87","author":"Fan","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"R12-20250802","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.2196\/jmir.2935","article-title":"Internet Addiction Test (IAT): which is the best factorial solution?","volume":"15","author":"Faraci","year":"2013","journal-title":"J Med Internet Res"},{"key":"R13-20250802","doi-asserted-by":"crossref","first-page":"adv00590","DOI":"10.2340\/00015555-3922","article-title":"Factors associated with affective symptoms and quality of life in patients with atopic dermatitis.","volume":"101","author":"Ferrucci","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"R14-20250802","doi-asserted-by":"crossref","first-page":"211","DOI":"10.23736\/S2784-8671.21.07014-6","article-title":"Effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis: a preliminary report of real-world data.","volume":"157","author":"Ferrucci","year":"2022","journal-title":"Ital J Dermatol Venereol"},{"issue":"1_suppl","key":"R15-20250802","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1177\/1203475418803628","article-title":"Approach to the assessment and management of adult patients with atopic dermatitis: a consensus document. section II: tools for assessing the severity of atopic dermatitis.","volume":"22","author":"Gooderham","year":"2018","journal-title":"J Cutan Med Surg"},{"key":"R16-20250802","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1017\/neu.2020.23","article-title":"Interleukin-4 and anxiety in adults with atopic dermatitis.","volume":"32","author":"Gray","year":"2020","journal-title":"Acta Neuropsychiatr"},{"key":"R17-20250802","doi-asserted-by":"crossref","first-page":"Article27","DOI":"10.2202\/1544-6115.1302","article-title":"On the operational characteristics of the benjamini and hochberg false discovery rate procedure.","volume":"6","author":"Green","year":"2007","journal-title":"Stat Appl Genet Mol Biol"},{"key":"R18-20250802","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","article-title":"The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group.","volume":"10","author":"Hanifin","year":"2001","journal-title":"Exp Dermatol"},{"key":"R19-20250802","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/exd.14563","article-title":"Impact of psychiatric comorbidities in psoriasis, hidradenitis suppurativa and atopic dermatitis: the importance of a psychodermatological approach.","volume":"31","author":"Iannone","year":"2022","journal-title":"Exp Dermatol"},{"key":"R20-20250802","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/s12888-021-03389-7","article-title":"COVID-19 related poor mental health and sleep disorders in rheumatic patients: a citizen science project.","volume":"21","author":"Ingegnoli","year":"2021","journal-title":"BMC Psychiatry"},{"key":"R21-20250802","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.3390\/ijerph18062923","article-title":"The independent role of body mass index (bmi) and severity of depressive symptoms on biological changes of women affected by overweight\/obesity.","volume":"18","author":"Iodice","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"R22-20250802","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2466\/pr0.1997.80.1.83","article-title":"The Lie\/Bet Questionnaire for screening pathological gamblers.","volume":"80","author":"Johnson","year":"1997","journal-title":"Psychol Rep"},{"key":"R23-20250802","doi-asserted-by":"crossref","first-page":"100042","DOI":"10.1016\/j.xjidi.2021.100042","article-title":"A literature review of real-world effectiveness and safety of dupilumab for atopic dermatitis.","volume":"1","author":"Kamata","year":"2021","journal-title":"JID Innov"},{"key":"R24-20250802","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s43440-022-00423-7","article-title":"The potential action of SSRIs in the treatment of skin diseases including atopic dermatitis and slow-healing wounds.","volume":"74","author":"Kiecka","year":"2022","journal-title":"Pharmacol Rep"},{"key":"R25-20250802","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis.","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"key":"R26-20250802","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1111\/all.14783","article-title":"Association between ambient air pollution and development and persistence of atopic and non-atopic eczema in a cohort of adults.","volume":"76","author":"Lopez","year":"2021","journal-title":"Allergy"},{"key":"R27-20250802","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1477-7525-7-64","article-title":"Evaluation of the impact of fibromyalgia on patients\u2019 sleep and the content validity of two sleep scales.","volume":"7","author":"Martin","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"R28-20250802","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/00015550510032832","article-title":"Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis.","volume":"85","author":"Mazzotti","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"R29-20250802","first-page":"174","article-title":"Association of clinical features and systemic immune-inflammation index with psychological distress in acne vulgaris.","volume":"35","author":"Namli","year":"2022","journal-title":"Dusunen Adam J Psychiatr Neurol Sci"},{"key":"R30-20250802","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.3390\/ijms21186484","article-title":"Genetic and epigenetic aspects of atopic dermatitis.","volume":"21","author":"Nedoszytko","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R31-20250802","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.neubiorev.2020.08.013","article-title":"Systematic review and meta-analysis of epidemiology of internet addiction.","volume":"118","author":"Pan","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"R32-20250802","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2340\/00015555-1246","article-title":"Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus.","volume":"92","author":"Phan","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"R33-20250802","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/jdv.17708","article-title":"Addictions in patients with atopic dermatitis: a cross-sectional pilot study in Germany.","volume":"36","author":"Pilz","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R34-20250802","doi-asserted-by":"crossref","first-page":"110347","DOI":"10.1016\/j.jpsychores.2020.110347","article-title":"Suicidal risks with psoriasis and atopic dermatitis: systematic review and meta-analysis.","volume":"141","author":"Pompili","year":"2021","journal-title":"J Psychosom Res"},{"key":"R35-20250802","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40257-021-00647-y","article-title":"The role of diet modification in atopic dermatitis: navigating the complexity.","volume":"23","author":"Rustad","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"R36-20250802","doi-asserted-by":"crossref","first-page":"e27835","DOI":"10.2196\/27835","article-title":"Conceptualizations of cyberchondria and relations to the anxiety spectrum: systematic review and meta-analysis.","volume":"23","author":"Schenkel","year":"2021","journal-title":"J Med Internet Res"},{"key":"R37-20250802","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jaip.2019.08.030","article-title":"Atopic eczema in adulthood and risk of depression and anxiety: a population-based cohort study.","volume":"8","author":"Schonmann","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R38-20250802","doi-asserted-by":"crossref","first-page":"e5411","DOI":"10.1097\/MD.0000000000005411","article-title":"Psychiatry outpatient visits by atopic dermatitis patients varying in the complexity of their prescriptions: a nationwide cohort study conducted from 2005 to 2013.","volume":"95","author":"Shin","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"R39-20250802","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis.","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"key":"R40-20250802","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0306-4603(82)90005-3","article-title":"The drug abuse screening test.","volume":"7","author":"Skinner","year":"1982","journal-title":"Addict Behav"},{"key":"R41-20250802","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11920-020-01179-8","article-title":"Recent insights into cyberchondria.","volume":"22","author":"Starcevic","year":"2020","journal-title":"Curr Psychiatry Rep"},{"key":"R42-20250802","first-page":"e384","article-title":"A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis.","volume":"37","author":"Stingeni","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R43-20250802","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/jdv.17111","article-title":"Pruritus intensity scales across europe: a prospective validation study.","volume":"35","author":"Storck","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R44-20250802","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12931-022-02266-5","article-title":"Associations of symptoms of anxiety and depression with health-status, asthma control, dyspnoea, dysfunction breathing and obesity in people with severe asthma.","volume":"23","author":"Stubbs","year":"2022","journal-title":"Respir Res"},{"key":"R45-20250802","doi-asserted-by":"crossref","first-page":"884143","DOI":"10.3389\/fphar.2022.884143","article-title":"Investigational drugs for the treatment of depression (part 1): monoaminergic, orexinergic, GABA-Ergic, and anti-inflammatory agents.","volume":"13","author":"Vasiliu","year":"2022","journal-title":"Front Pharmacol"},{"key":"R46-20250802","doi-asserted-by":"crossref","first-page":"152167","DOI":"10.1016\/j.comppsych.2020.152167","article-title":"Is cyberchondria a new transdiagnostic digital compulsive syndrome? a systematic review of the evidence.","volume":"99","author":"Vismara","year":"2020","journal-title":"Compr Psychiatry"},{"key":"R47-20250802","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/cpb.1998.1.237","article-title":"Internet addiction: the emergence of a new clinical disorder.","volume":"1","author":"Young","year":"1998","journal-title":"CyberPsychology & Behavior"},{"key":"R48-20250802","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/ced.15212","article-title":"Association between moderate to severe atopic dermatitis and lifestyle factors in the dutch general population.","volume":"47","author":"Zhang","year":"2022","journal-title":"Clin Exp Dermatol"}],"container-title":["International Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/YIC.0000000000000511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T18:05:10Z","timestamp":1754157910000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/YIC.0000000000000511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,22]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/yic.0000000000000511","relation":{},"ISSN":["0268-1315"],"issn-type":[{"value":"0268-1315","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,22]]}}}